ROPINIROLE
- Product NDC
- 72189-222
- Requested package NDC
- 72189-222-30
- 11-digit product format
- 721890222
- Labeler code
- 72189
- Product ID
- 72189-222_2c28281e-fe37-b7e4-e063-6294a90ad4f7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ROPINIROLE
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- DIRECT RX
- Application
- ANDA204022
- Marketing category
- ANDA
- Marketing start
- 2021-05-20
- Substance
- ROPINIROLE HYDROCHLORIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 72189-222 | 72189-222-30 | U | Excluded because listing certification expired | excluded / ndc_excluded.zip | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 72189-222 | 72189-222-30 | U | Excluded because listing certification expired | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204022-001 | ROPINIROLE HYDROCHLORIDE | ROPINIROLE HYDROCHLORIDE | EQ 0.25MG BASE | TABLET / ORAL | AB | 2017-02-28 | |
| A204022-002 | ROPINIROLE HYDROCHLORIDE | ROPINIROLE HYDROCHLORIDE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2017-02-28 | |
| A204022-003 | ROPINIROLE HYDROCHLORIDE | ROPINIROLE HYDROCHLORIDE | EQ 1MG BASE | TABLET / ORAL | AB | 2017-02-28 | |
| A204022-004 | ROPINIROLE HYDROCHLORIDE | ROPINIROLE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2017-02-28 | |
| A204022-005 | ROPINIROLE HYDROCHLORIDE | ROPINIROLE HYDROCHLORIDE | EQ 3MG BASE | TABLET / ORAL | AB | 2017-02-28 | |
| A204022-006 | ROPINIROLE HYDROCHLORIDE | ROPINIROLE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2017-02-28 | |
| A204022-007 | ROPINIROLE HYDROCHLORIDE | ROPINIROLE HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2017-02-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A204022-001 | AB |
| A204022-002 | AB |
| A204022-003 | AB |
| A204022-004 | AB |
| A204022-005 | AB |
| A204022-006 | AB |
| A204022-007 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A204022-001 | ROPINIROLE HYDROCHLORIDE | EQ 0.25MG BASE | TABLET / ORAL | AB | 2017-02-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204022-002 | ROPINIROLE HYDROCHLORIDE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2017-02-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204022-003 | ROPINIROLE HYDROCHLORIDE | EQ 1MG BASE | TABLET / ORAL | AB | 2017-02-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204022-004 | ROPINIROLE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2017-02-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204022-005 | ROPINIROLE HYDROCHLORIDE | EQ 3MG BASE | TABLET / ORAL | AB | 2017-02-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204022-006 | ROPINIROLE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2017-02-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204022-007 | ROPINIROLE HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2017-02-28 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204022-001 | ROPINIROLE HYDROCHLORIDE | EQ 0.25MG BASE | TABLET / ORAL | AB | 2017-02-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204022-002 | ROPINIROLE HYDROCHLORIDE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2017-02-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204022-003 | ROPINIROLE HYDROCHLORIDE | EQ 1MG BASE | TABLET / ORAL | AB | 2017-02-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204022-004 | ROPINIROLE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2017-02-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204022-005 | ROPINIROLE HYDROCHLORIDE | EQ 3MG BASE | TABLET / ORAL | AB | 2017-02-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204022-006 | ROPINIROLE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2017-02-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204022-007 | ROPINIROLE HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2017-02-28 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204022-001 | ROPINIROLE HYDROCHLORIDE | EQ 0.25MG BASE | TABLET / ORAL | AB | 2017-02-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204022-002 | ROPINIROLE HYDROCHLORIDE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2017-02-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204022-003 | ROPINIROLE HYDROCHLORIDE | EQ 1MG BASE | TABLET / ORAL | AB | 2017-02-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204022-004 | ROPINIROLE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2017-02-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204022-005 | ROPINIROLE HYDROCHLORIDE | EQ 3MG BASE | TABLET / ORAL | AB | 2017-02-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204022-006 | ROPINIROLE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2017-02-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204022-007 | ROPINIROLE HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2017-02-28 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204022-001 | ROPINIROLE HYDROCHLORIDE | EQ 0.25MG BASE | TABLET / ORAL | AB | 2017-02-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204022-002 | ROPINIROLE HYDROCHLORIDE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2017-02-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204022-003 | ROPINIROLE HYDROCHLORIDE | EQ 1MG BASE | TABLET / ORAL | AB | 2017-02-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204022-004 | ROPINIROLE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2017-02-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204022-005 | ROPINIROLE HYDROCHLORIDE | EQ 3MG BASE | TABLET / ORAL | AB | 2017-02-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204022-006 | ROPINIROLE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2017-02-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204022-007 | ROPINIROLE HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2017-02-28 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204022-001 | ROPINIROLE HYDROCHLORIDE | EQ 0.25MG BASE | TABLET / ORAL | AB | 2017-02-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204022-002 | ROPINIROLE HYDROCHLORIDE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2017-02-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204022-003 | ROPINIROLE HYDROCHLORIDE | EQ 1MG BASE | TABLET / ORAL | AB | 2017-02-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204022-004 | ROPINIROLE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2017-02-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204022-005 | ROPINIROLE HYDROCHLORIDE | EQ 3MG BASE | TABLET / ORAL | AB | 2017-02-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204022-006 | ROPINIROLE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2017-02-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204022-007 | ROPINIROLE HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2017-02-28 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204022-001 | ROPINIROLE HYDROCHLORIDE | EQ 0.25MG BASE | TABLET / ORAL | AB | 2017-02-28 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204022-002 | ROPINIROLE HYDROCHLORIDE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2017-02-28 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204022-003 | ROPINIROLE HYDROCHLORIDE | EQ 1MG BASE | TABLET / ORAL | AB | 2017-02-28 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204022-004 | ROPINIROLE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2017-02-28 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204022-005 | ROPINIROLE HYDROCHLORIDE | EQ 3MG BASE | TABLET / ORAL | AB | 2017-02-28 | 03ed91905a0d… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A204022-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A204022-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A204022-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A204022-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A204022-005 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A204022-006 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A204022-007 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204022-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204022-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204022-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204022-004 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204022-005 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204022-006 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204022-007 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A204022-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A204022-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A204022-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A204022-004 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A204022-005 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A204022-006 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A204022-007 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204022-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204022-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204022-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204022-004 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204022-005 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204022-006 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204022-007 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204022-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204022-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204022-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204022-004 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204022-005 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204022-006 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204022-007 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204022-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204022-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204022-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204022-004 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204022-005 | AB | 1 | 03ed91905a0d… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ROPINIROLE
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ROPINIROLE HYDROCHLORIDE | 1 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| D7ZD41RZI9 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 314208 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| c2c38b4c-b139-45f2-e053-2995a90a262c | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dc920868-8845-b908-7ca8-0dee3e345af5 | Product name | 2 | 20230123 |
| e24bc1b4-1e16-908e-3d09-29da3ca2fb1f | Product name | 2 | 20170517 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72189-222-30 | ROPINIROLE | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 3 | |
| 72189-222-60 | ROPINIROLE | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72189-222-30 | EA - Each | 72189-222 | 1d8b8770-10a8-4fa6-b0e4-ff949053bcbc | 1 | 2022-01-06 |
| 72189-222-60 | EA - Each | 72189-222 | 308448a2-b950-47a4-ae4e-80ebe12ce003 | 1 | 2021-06-02 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ropinirole | ROPINIROLE | Direct_Rx | e1fb0b51-4f8a-965d-e053-2a95a90ad936 | 2025-01-22 | Warnings, Adverse reactions | 204022 ANDA204022 |
| ROPINIROLE | ROPINIROLE | DIRECT RX | c2c38b4c-b139-45f2-e053-2995a90a262c | 2025-01-20 | Warnings, Adverse reactions | 204022 ANDA204022 72189-222-30 72189-222 72189022230 |
| ropinirole | ROPINIROLE | Bryant Ranch Prepack | 8ebaa083-9f72-4e43-a4c4-36e3e7b5d5f2 | 2024-10-31 | Warnings, Adverse reactions | 204022 ANDA204022 |
| ropinirole | ROPINIROLE | Bryant Ranch Prepack | ceb3a0cb-8677-4acd-8313-5498201e81d9 | 2024-10-31 | Warnings, Adverse reactions | 204022 ANDA204022 |
| ropinirole | ROPINIROLE | Bryant Ranch Prepack | cb378fb5-6dca-43e9-83bc-3c54eb9c1af7 | 2024-10-31 | Warnings, Adverse reactions | 204022 ANDA204022 |
| ropinirole | ROPINIROLE | Bryant Ranch Prepack | 55bb5cf4-0e12-41b0-bc52-50b26fe408de | 2024-10-31 | Warnings, Adverse reactions | 204022 ANDA204022 |
| ropinirole | ROPINIROLE | Accord Healthcare Inc. | 4a2a5b63-5b14-6975-e054-00144ff8d46c | 2024-10-03 | Warnings, Adverse reactions | 204022 ANDA204022 |
| ropinirole | ROPINIROLE | A-S Medication Solutions | 4f4729f8-c910-4a09-a4b4-b4243e7f0105 | 2024-01-08 | Warnings, Adverse reactions | 204022 ANDA204022 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 314208 | rOPINIRole HCl 1 MG Oral Tablet | PSN | c2c38b4c-b139-45f2-e053-2995a90a262c | 3 |
| 314208 | ropinirole 1 MG Oral Tablet | SCD | c2c38b4c-b139-45f2-e053-2995a90a262c | 3 |
| 314208 | ropinirole 1 MG (as ropinirole hydrochloride) Oral Tablet | SY | c2c38b4c-b139-45f2-e053-2995a90a262c | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 72189-222-30 | 72189022230 | 30 TABLET, FILM COATED in 1 BOTTLE (72189-222-30) | 2021-05-20 | 0000-00-00 | No | No | Current |